Skip to main content
. 2020 Jul 23;34:2058738420942375. doi: 10.1177/2058738420942375

Figure 2.

Figure 2.

The difference in mortality rate among patients with IIAT and non-IIAT with ESBL-negative BSI divided by qSOFA score < 2 and qSOFA score ≧ 2. There is no significant different of mortality between non-IIAT and IIAT patients with ESBL-negative bacteremia qSOFA score < 2 (P = 0.170) and qSOFA score ≧ 2 (P = 0.392).

BSL: bloodstream infection; ESBL: extended-spectrum beta-lactamase; IIAT: inappropriate initial antibiotic therapy; qSOFA: quick sepsis-related organ failure assessment.